Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Inari Medical, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 May 2023, 16:37.
Jonathan D. Root - 27 May 2023 Form 4 Insider Report for Inari Medical, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 27 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 May 2023, 16:37:17 UTC
- Prior SEC filing
- 19 May 2023
- Next SEC filing
- 14 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Angela Ahmad, attorney-in-fact for Jonathan Root, M.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan D. Root filed Form 4 for Inari Medical, Inc. on 30 May 2023.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NARI
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,982
- Change %
- +0.56%
- Price
- $0.000000
- Shares after
- 537,023
- Date
- 27 May 2023
- Ownership
- Direct
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 335
- Date
- 27 May 2023
- Ownership
- Directly Owned by Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NARI
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -2,982
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 27 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,982
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of common stock for each RSU. 1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years.